Delivery Order SPE2DB25D2203-SPE2DB25FPRTL

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,091.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, valued at $10,862.22, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of January 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,866.00 and an ultimate completion date of October 30, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Defense Logistics Agency (DLA). The $2,316.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,851.16 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $1,448.28 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract has an ultimate completion date of July 9, 2024 and does not utilize a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 1000S to the Defense Logistics Agency (DLA). The $30,500.09 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024 with a completion date of September 4, 2024. The contract is a delivery order type, without any set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,328.90. The contract has an ultimate completion date of October 20, 2023 and is structured as a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Defense Logistics Agency (DLA). The $2,892.49 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 1000S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 29, 2024, with a ceiling value of $12,453.95. The contract has a firm fixed-price pricing type and an ultimate completion date of December 2, 2024. This contract is a delivery order, and there is no set-aside designation mentioned....
  • SPE2DB25D2203
    Indefinite Delivery Contract
  • SPE2DB25D2203-SPE2DB25FPRTL
    Delivery Order

This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,091.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:51 AM